T32 Alumni

<< Back to Current T32 Fellows

Cory Stingl, M.D.

Funding supported by T32 Grant, 2017 -2019
Research: My research is on a group of conditions called the juvenile idiopathic inflammatory myopathies. They are a rare group of autoimmune conditions that affect predominantly the muscles in children but very frequently affect the skin and less frequently other organ systems like the lungs. Compared to other children with autoimmune disease, such as juvenile idiopathic arthritis, they tend to have slower response to treatment, more problems from their condition, and more side effects from exposure to protracted treatment courses with steroids. Our goal is to study whether findings on exams, standard blood tests, autoantibody profiles, and gene expression profiles coupled with machine learning can identify clinically meaningful subgroups that help predict, amongst other things, response to treatment.
Current Position: Pediatric Rheumatologist, Duke Medical Center

Carolyn Baloh, M.D.

Funding supported by T32 Grant, 2017 -2019
Research: My research is entitled “Novel genetic models of common variable immune deficiency (CVID).” CVID is the most common immunodeficiency comprising 30% of all immunodeficiencies. The disease is associated with significant morbidity as patients are prone to recurrent infections, autoimmune disease, and malignancy. The morbidities can also place patients at higher risk of death. To date, we have identified only 10 percent of all genetic mutations associated with this disease. I am working on a project that will involve identifying further genetic defects and then creating mouse models of the defects to better characterize the disease and novel therapies.
Current Position: Advanced Researach Fellow, Duke University

L. Gayani Tillekeratne

Funding supported by the K Award, 2017-2019
Research: I received a career development award through the National Institute of Allergy and Infectious Disease (NIAID) to study the epidemiology of acute respiratory tract infections among patients hospitalized in Sri Lanka. As part of this work, I will be evaluating the performance of host gene expression signatures developed by the CAGPM team to distinguish viral versus bacterial respiratory tract infections. I will determine how well these signatures perform in the Sri Lankan setting, refine the signatures, and validate them along with host biomarkers such as procalcitonin in a prospective cohort of patients with acute respiratory tract infections.